11 C]PIB data scaled in standardized uptake values (SUVs). The frame in which maximal uptake occurred was defined for each subject (ie, "peak"). The concentration (SUV) for each region at the individual's peak, during the 3.5-4 minute time interval and for the initial 6 minute sum, was determined. R1 (ie, relative delivery using cerebellum as reference tissue) from the simplified reference tissue model 2 was determined for each region. PIB SUVs were compared to the absolute CBF global and regional values (in mL/minute/100 mL) and the R1 values were compared to the cerebellar-normalized rCBF. RESULTS: Significant linear relationships were found for all SUV measures with measures of absolute global and regional CBF that were comparable to the relationship between normalized CBF and R1. The individual SUV peak exhibited the strongest relationship both regionally and globally. All individuals and all regions had highly significant regression slopes. Age, gender, or amyloid burden did not influence the relationship. CONCLUSION: Early PIB uptake has the potential to effectively serve as a surrogate for global and regional CBF measures. The simple and readily obtainable individual's SUV peak value was the strongest predictor regionally and globally of CBF.
Introduction
Cardiovascular risk factors 1 and cerebrovascular dysfunction 2 have been associated with an enhanced risk for the development of Alzheimer's disease (AD). The existence of common risk factors and the positive effects of the treatment of vascular risk factors on cognitive decline in patients with AD without cerebrovascular disease 3 reinforce 1 the view that in the least, the pathologies are linked. Storkebaum et al 4 detail "a vicious circle of reciprocal interactions between β-amyloid accumulation and vascular defects that ultimately can lead to hypoperfusion and metabolic demise of neuronal and vascular cells." The data-driven model of late-onset Alzheimer's disease, in contrast to the hypothetical progression model, cites the critical role of vascular dysfunction as the "earliest/strongest altered event, followed by Aβ deposition . . . " 5 Because of these critical links, assessments of developing Alzheimer's pathology should ideally address both cerebrovascular function and amyloid pathology. The mechanism of action for the amyloid imaging agents involves a wash-in/wash-out of the radiotracer with retention in the amyloid neuritic plaques. The potential of the initial phase of the amyloid study to reflect cerebral blood flow (CBF) has been recognized. Reports have compared CBF to estimates derived from the summed early phase [ 11 C]PIB images (6 minutes, 6 ,7 1-4 minutes 8 ), and WARM (washout allometric reference method) 9, 10 and the normalized CBF (to cerebellum) to the R1 parameter from the standard reference tissue model. 11 These techniques are generally computationally demanding (eg, R1 or WARM) or produce relative CBF measures only. 12 It was the purpose of this research to explore the potential of readily derived, early PIB-based parameters and demographic information to model absolute global and regional CBF as determined by the gold-standard, quantitative [ 15 O]water PET imaging. This research was based on the hypothesis that early phase [ 11 C]PIB uptake, globally and regionally, is significantly related to global and regional measures of CBF, respectively. If a clinically accessible metric, CBF regional mean = 8.57 SUV peak + 6.68 R 2 = .60 (P < .0001) CBF regional rest = 8.52 SUV peak + 6.79 R 2 = .58 (P < .0001) *All coefficients significant at the P < .0001 level. Condition = rest, count, memory condition, or mean of conditions; PIB-derived measures = standardized uptake values (SUVs) by timeframe (peak, 3.5-4 minutes frame, 6 minute sum).
significantly related to CBF can be established for [ 11 C]PIB, then the stage is set for extension of this methodology to alternative amyloid agents with widespread clinical use potential, ie, F-18 labeled radiotracers. If that goal is realized, a single agent in a single scan session could be used to define both the functional (CBF) and pathological (amyloid burden) status of a patient at-risk for vascular and/or Alzheimer's dementia.
Methods Participants
Twenty-four participants underwent the imaging procedures. The sample consisted of 8 females and 16 males, ranging in age from 57 to 87 years (mean = 70.0 ± 10.0 year, males = 68.0 ± 10.5, females = 73.9 ± 8.2) and represented the cognitive (Fig 2A, upper row) and [ 11 C]PIB individual peak image (30 second time interval at 180-210 seconds postinjection in SUV units) (Fig 2A, lower row) . The PIB peak image is noisier than the [ 15 O]water CBF image but has similar information content regarding the distribution of cerebral blood flow as illustrated by the plot of regional [ 15 O]water CBF versus PIB SUV peak (Fig 2B) . For comparison purposes, the plot of [ 15 O]water CBF from the rest versus the counting task is presented (Fig 2C) .
spectrum from healthy controls to mild cognitive impairment (MCI) (MMSE 23-30). Participants were excluded if they were unable to undergo MR imaging, had a history of or current diagnosis of major psychiatric disease (other than dementia), a history of abuse of psychoactive substances or medications, a history of stroke, a history of head injury with loss of consciousness for greater than 30 minutes, or a history of other neurological disorder or systemic illness that could potentially affect cognition or brain function (outside of a diagnosis MCI) or could affect their safety or comfort while undergoing the imaging studies. The study was approved by the University of Iowa Institutional Review Board and Medical Radiation 
Imaging Procedures
Imaging consisted of structural MRI and two different positron emission tomography (PET) imaging sessions: (1) blood sampling. Technical methodology was implemented as described for work at this institution. [13] [14] [15] Dynamic imaging and arterial blood sampling commenced at tracer injection and continued for 100 seconds (5 seconds/frame × 20 frames). Dynamic data were iteratively reconstructed (Gaussian 5.0, 2 iterations/8 subsets, attenuation, scatter, decay, and deadtime correction = ON). Parametric images were calculated from the summed activity images (40 seconds postbolus transit) and the arterial blood curve using the autoradiographic model in the pixel-wise modeling module (PXMOD). CBF measurements were performed under three conditions-a rest condition, during performance of a simple cognitive task (counting), and while remembering a prelearned word list. The "rest" condition mimicked that employed for studies designed to delineate the default mode network, 16 whereas counting represents an overlearned simple cognitive task with few cognitive demands and list remembering constitutes task-based changes in blood flow. Since "rest" is a relatively uncontrolled condition that may be imperfectly reproduced between the two imaging sessions with respect to cognitive activity and differs in imaging duration and sequence of injections, comparisons were made to all three measures of CBF individually as well as the average of the measurements, ie, CBF mean .
[
O]Water PET Image Processing
Water parametric blood flow images were coregistered to the T1-weighted MRI using the Fusion tool (rigid matching configuration using normalized mutual information routine) of PMOD Biomedical Image Quantification, version 3.9 (PMOD Technologies, Ltd.). Global CBF (gCBF) was determined for each injection of [ 15 O]water by volume-weighted averaging of the flow values for all regions defining intracerebral pixels as determined from brain parcellation analysis of the coregistered MRI. For each subject, there were four measures of global CBF-one for each activation condition (count, memory, and rest) and average of these three measures (ie, CBF global mean ). Regional CBF (rCBF) was determined for each lobar, cortical, and subcortical region defined on the coregistered T1 MRI using the maximum probability atlas 17 (N = 78 regions/subject) of Neuro Tool of PMOD for each activation condition as well as the average of the three conditions (ie, CBF regional mean ). PIB peak = standardized uptake value (SUV) at the individual's peak; PIB SUV 3.5-4min = SUV during the frame acquired from 3.5 to 4 minutes postadministration; PIB SUV 6min = SUV calculated from the sum of the first 6 minutes postadministration; R1 = relative delivery using cerebellum as reference tissue calculated from the simplified reference tissue model 2 (SRTM2); SD = standard deviation; CV% = coefficient of variation expressed as a percent of the mean.
PIB (555 ± 10% MBq) (15 ± 10% mCi) was administered as an IV bolus at rest, imaged dynamically for 90 minutes (4 × 15 seconds, 8 × 30 seconds, 9 × 60 seconds, 2 × 180 seconds, 14 × 300 seconds), and the images were iteratively reconstructed (Gaussian 3.0, 6 iterations/16 subsets, zoom = 2.6, attenuation, scatter, decay, and deadtime correction = ON). A summed image was created with the data from 50 to 70 minutes postadministration. Both the dynamic frames and the summed image were converted to standardized uptake value (SUV) images.
[ 11 C]PIB PET Image Processing
Dynamic imaging commenced at injection and continued over a 90 minute period. The early phase of the dynamic sequence (ie, first 6 minutes, see below) was used to characterize CBF and the latter phase for amyloid burden. The dynamic images were coregistered to the anatomical MRI for tissue and region definition. Time-activity curves were created for each participant's regional [ 11 C]PIB data (PNEURO PMOD) scaled in SUVs (N = 24 × 78 regions/participant = 1,872 regions). The time frame in which the maximal uptake occurred for the mean of all regions was defined for each participant (ie, "peak"). See Figure 1 . The concentrations (SUV units) were determined for each region and for a volume-weighted global value for each of the following time intervals: r SUV peak : Individual's peak (30 second interval) r SUV 3.5-4 min : 3.5-4 minute time interval (latest individual peak = frame 10) r SUV 6 min : Initial 6 minute sum.
The rationale for each of these SUV-based measures is that the peak represents the end of the wash-in phase for that particular participant, whereas the 3.5-4 minute time interval represents the latest time for any of the participants peak values and therefore, would constitute a time window of general applicability. The sum over the first 6 minutes represents a time window employed by Forsberg et al 6 and Gietl et al 7 when reporting on the utility of PIB as a potential dual pathology tracer. The global and regional PIB SUVs were compared to the absolute CBF global and regional values (rCBF) for each condition and to the mean global and regional CBF values, respectively. The regional R1 values (ie, relative delivery derived from distribution volume ratio (DVR) analyses described below) were compared to the cerebellar-normalized rCBF (ie, specific region's absolute CBF divided by the absolute CBF in the bilateral cerebellum) because R1 values are inherently relative to the cerebellum.
The entire 90 minute sequence and the time interval between 50 and 70 minutes were used for quantifying the amyloid burden using methods previously described. [18] [19] [20] The regional distribution volume normalized by the nonspecific retention in the reference region (cerebellum), referred to as DVR, was determined for each region from the simplified reference tissue model 2 (SRTM2) using the cerebellum as the reference tissue as implemented by the kinetic modeling tool (PKIN PMOD) was the primary measure used to assess amyloid burden. The standardized uptake volume ratio (SUVR normalized to cerebellar gray matter) for the interval from 50 to 70 minutes was also calculated as an alternate measure of the amyloid burden. The cortical retention ratios (CRR = volume-weighted mean of AD-related tissues) were calculated for each individual based on the regional DVR and SUVR values by calculating the mean gray matter values averaged across the lateral and medial frontal, anterior and posterior cingulate, lateral parietal, and lateral temporal regions as described by Landau et al. 21 
Statistical Analyses
All analyses were designed to compare PIB SUV measures with global and regional CBF measures. Analyses consisted of simple linear regression models with CBF as the outcome measure and PIB SUV as the predictor variable. The intercept was set equal to zero to force the model through the origin. Linear mixed models were used to account for the within subject correlation via a random intercept to include multiple regional values in the same analysis. These models were performed with and without inclusion of potentially relevant demographic information (eg, age and sex). The models were compared based on the R 2 value and the P value associated with the slope coefficient.
Results

Comparison between Early [ 11 C]PIB and [ 15 O]Water CBF
The peak SUV occurred at 105-225 seconds postinitiation of the bolus injection. Regression models were used to evaluate the relationship between early PIB SUV measures (specifically, the individual participant's peak (SUV peak ), the fixed early timeframe (SUV 3.5-4min ), and the initial 6 minute summed image (SUV 6min ) versus global and regional CBF measures). All of the early PIB SUV measures exhibited positive slopes, significantly different from zero, when regressed to the global and regional CBF measures determined from each of the tasks (counting, memory, and rest) as well as the mean of all CBF measures. With the exception of the 6 minute summed image SUV (SUV 6min ) for which the highest R 2 value was observed for the comparison with CBF global count , the highest R 2 values were observed for the comparisons with the mean CBF values for both comparisons to the participant's global measures and the individual anatomical regional CBF. Therefore, Table 1 presents results for the analyses with the regional and global mean CBF comparisons. Regression analyses were performed for each subject (N = 24) and region separately (N = 78) to relate CBF mean to SUV peak . Figure 2 illustrates an example image along with plots of the individual's regional CBF values versus SUV peak values and the individual's reproducibility between two different tasks (rest vs. counting). Although noisier than the [ 15 O]water images, the early PIB images obviously display a similar blood flow pattern across the entire brain without anatomical discrepancies. Figure 3 plots regional CBF mean versus PIB SUV peak for all individuals along with the individual's fitted regression lines with Figure 4 presenting the corresponding reproducibility of two separate CBF measures using [ 15 O]water PET for consecutive but not identical cognitive tasks (rest vs. counting). The enhanced variability illustrated in Figure 3 compared to Figure 4 represents the uncertainty associated with using the PIB-based measure for CBF compared to the gold-standard [ 15 O]water PET.
Every individual participant (N = 24) exhibited statistically significant correlational relationships between CBF mean and PIB SUV peak at the P < .0001 level (r = .73-.90) (see Table 2 and Fig 5) that would remain significant even with a Bonferroni correction (using a .05/24 = .002 level of significance).
Every region (N = 78) exhibited statistically significant positive correlations (r = .44-.82) between CBF mean and PIB SUV peak (Table 3) . Of these regions, 35 of 78 would remain significant even with a Bonferroni correction (using a .05/78 = .0006 of significance). Figure 6 illustrates the consistency across all the brain anatomical regions between the mean [
15 O]water and PIB SUV peak estimates of CBF. All PIB-based rCBF estimates were within the ±1 SD of the rCBF measures derived from [ 15 O]water. Age and gender were not significant parameters in describing the relationship between the early PIB measures and CBF (data not shown). As was the case for the first five participants illustrated in Figure 1 , the CRR was not related to any of the early PIB measures (data not shown).
Comparison between [ 11 C]PIB R1 and [ 15 O]Water CBF
Statistically significant relationships, based on simple linear regressions and correlations, were observed between the CBF mean values derived from [ 15 O]water and R1 (relative tracer delivery derived from the SRTM2 analysis of the dynamic PIB data) for the composite data set and each individual participant; however, significant correlations were not observed for all anatomical regions, even when comparing to the cerebellar-normalized CBF values (see Table 3 , farthest right-hand column). Furthermore, the correlations between CBF values and R1 were lower than those observed between CBF and PIB SUV peak (eg, R 2 = .39 vs. R 2 = .52, respectively), but, as expected, was higher when compared to the cerebellar-normalized CBF (R 2 = .64).
Discussion
The importance of compromises in CBF, not only in cerebrovascular disease, but in the early Alzheimer's pathological cascade is being recognized. HMPAO or BOLD MRI, and absolute CBF such as ASL MRI, have been evaluated. The current work presents another promising technique, early phase PIB, with the potential to determine both relative CBF (ie, distribution throughout the brain) and absolute CBF (ie, in terms of mL/minute/100 mL tissue). Early phase PIB, particularly the SUV peak , has the advantages of being computationally PIB peak = standardized uptake value (SUV) at the individual's peak; PIB SUV 3.5-4min = SUV during the frame acquired from 3.5 to 4 minutes postadministration; PIB SUV 6min = SUV calculated from the sum of the first 6 minutes postadministration; R1 = relative delivery using cerebellum as reference tissue calculated from the simplified reference tissue model 2 (SRTM2); R1 vs NormCBF = R1 compared to the cerebral blood flow (CBF) normalized by cerebellar CBF; SD = standard deviation; CV% = coefficient of variation expressed as a percent of the mean. Region definitions: l = left, r = right; Amygdala = amygdala; Ant TL inf lat = anterior temporal lobe, lateral part; Ant TL med = anterior temporal lobe, medial part; Brainstem = brainstem; CaudateNucl = caudate nucleus; Cerebellum = cerebellum; Corp Callosum = corpus callosum; FL inf fr G = inferior frontal gyrus; FL mid fr G = middle frontal gyrus; FL OFC AOG = anterior orbital gyrus; FL OFC LOG = lateral orbital gyrus; FL OFC MOG = medial orbital gyrus; FL OFC POG = posterior orbital gyrus; FL precen G = precentral gyrus; FL strai G = straight gyrus; FL sup fr G = superior frontal gyrus; G cing ant = cingulate gyrus, anterior part; G cing post = cingulate gyrus, posterior part; G fus = fusiform gyrus; G paraH amb = parahippocampal and ambient gyri; G sup temp ant = superior temporal gyrus, anterior part; G sup temp post = superior temporal gyrus, posterior part; G tem midin = middle and inferior temporal gyrus; Hippocampus = hippocampus; Insula = insula; NuclAccumb = nucleus accumbens; OL cuneus = cuneus; OL ling G = lingual gyrus; OL rest lat = lateral remainder of occipital lobe; Pallidum = pallidum; PL postce G = postcentral gyrus; PL rest = lateral remainder of occipital lobe; PL sup pa G = superior parietal gyrus; Post TL = posterior temporal lobe; Presubgen antCing = presubgenual frontal cortex; Putamen = putamen; S nigra = substantia nigra; Subcall area = subcallosal area; Subgen antCing = subgenual frontal cortex; Thalamus = thalamus.
simple, anatomically independent, and informationally coupled with the determination of amyloid burden (ie, two pieces of ADrelevant information in one scan). Predictions of global and regional CBF can be based on the following equations:
CBF regional mean = 8.57SUV regional peak + 6.68,
where "global" represents values determined from averaging over the entire brain and "regional" represents values derived from individual anatomical regions. Equation (1) is derived from a simple linear regression of global mean values, whereas Equation (2) is derived from a linear mixed regression model using all of the individual's region-based values. The two models are equivalent at 33.4 mL/minute/100 mL or an SUV = 3.12.
The use of SUV peak does require some image-analysis work to determine the time at which the individual's peak value occurred. An even simpler and only marginally less reliable is the use of an SUV determined over a fixed time interval (in this case, 3.5-4 minutes). Both of these measures were superior to the use of the 6 minute average SUV. However, the small sample size that these conclusions are based on is a limitation of the study. The data reported in this paper were not collected solely for addressing the relationship between CBF and the early PIB parameters. Information was available on CBF under three different activation conditions-a simple memory task (counting), a more difficult memory task (remembering a prelearned word list), and rest. These conditions were acquired in that order-counting, memory, and rest-therefore, the rest condition was the third [ 15 O]water injection and was acquired when the individual had been on the scanner bed for approximately 45 minutes. The rest condition appears to be the appropriate comparison condition if what the participant was supposed to be "doing" at the time of imaging was the only consideration. However, the magnitude and distribution of CBF measures vary with factors beyond the task being performed. Although the participant was told to "rest" (eyes open and ears unplugged) for the PIB injection, it was the first injection of that particular session, a situation more analogous to the counting task. Second, "rest" for the [ 15 O]water injections was 100 seconds in duration, whereas "rest" for the PIB condition lasted for 6 minutes, a time frame during which the subject was likely to engage in cognitive activities. Since the brain is never in an "off" or even standard framework, "rest" is a variable condition from nearly asleep to full-blown cognitive engagement, depending on the participant and how comfortable and bored the individual may be. Therefore, because the conditions could not be matched exactly, comparisons were made between the early PIB parameters and each of the [
15 O]water conditions that were available as well as to the average (mean) of all three conditions. Figure 4 illustrates the reproducibility of two quantitative [ 15 O]water CBF determinations using different activation conditions and represents the potential underlying uncertainty of CBF determinations made on the same day using the same technique but minimally different activation conditions. The comparison of Figure 3 to Figure 4 illustrates the additional uncertainty of CBF determinations using the simpler, early phase PIB technique as well as differences incurred by making measurements on separate days.
Although promising, the major limitation of the early phase PIB technique as a surrogate for CBF is comparable to the limitation of PIB as an amyloid imaging agent-specifically, the [ 11 C] label on the radiopharmaceutical. Because of the relatively short half-life of [ 11 C] (20 minutes), PIB requires an onsite cyclotron and radiochemistry production facilities and, regulatorily, will always be an FDA IND (investigational new drug application) rather than an NDA or ANDA (new drug application = "approved") radiopharmaceutical. So, no matter how promising this technique may be, widespread adoption is unlikely. However, the mechanistic similarity between PIB and the other commercially available amyloid imaging agents ( Early PIB uptake has the potential to effectively serve as a surrogate for global and regional CBF measures. The strong correlation between PIB uptake and CBF may allow for a single imaging session to capture important clinical information on blood flow in addition to severity of amyloid load. Although all early PIB SUV metrics explored were significantly related to the absolute CBF for all subjects and for all regions across the brain, the simple and readily obtainable individual-specific SUV peak value was the strongest predictor regionally and globally. Reliable global and regional CBF measures along with an assessment of amyloid burden can be obtained with a single administration of [ 11 C]PIB.
